Details for New Drug Application (NDA): 213225
The generic ingredient in VOBRIG is leuprolide acetate. There is one drug master file entry for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
Summary for 213225
| Tradename: | VOBRIG |
| Applicant: | Sun Pharm |
| Ingredient: | leuprolide acetate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 213225
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;SUBCUTANEOUS | Strength | 28MG/2.8ML (10MG/ML) | ||||
| Approval Date: | Aug 26, 2026 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
